Clinical trial
Evaluation of Tamsulosin in the Treatment of Ureteral Stones
NCT00151567 · Rennes University Hospital, Other · Completed
Key facts
| NCT number | NCT00151567 |
|---|---|
| Title | Evaluation of Tamsulosin in the Treatment of Ureteral Stones |
| Official title | Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones |
| Acronym | TAMSULOSINE |
| Lead sponsor | Rennes University Hospital, Other |
| Collaborators | Ministry of Health, France Yamanouchi |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ureterolithiasis, Ureteral Calculi |
| Intervention type | Drug |
| Interventions | Tamsulosin, Placebo |
| Enrollment | 129 |
| Start date | Feb 1, 2002 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Dec 4, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: